Unilever Q3 Sales Rise, Backs FY21 Margin View; Declares Dividend - Quick Facts

Consumer goods giant Unilever plc. (UN,ULVR.L,UL) reported Thursday that its third-quarter turnover grew 4 percent to 13.45 billion euros from last year's 12.93 billion euros.

Underlying sales growth was 2.5 percent, with 4.1 percent increase in price, while volume dropped 1.5 percent.

Beauty & Personal Care sales were 5.69 billion euros. Underlying sales grew 2.6 percent, with 3.9 percent from price and negative 1.3 percent from volume.

Home Care underlying sales grew 1.4 percent. Foods & Refreshment underlying sales grew 3 percent.

Further, the Board has declared a quarterly interim dividend of 0.3598 pounds per Unilever PLC ordinary share or 0.4268 euro per Unilever PLC ordinary share.

Looking ahead, the company said it continues to expect to deliver in line with margin guidance of around flat for the full year.

Chief Executive Officer Alan Jope said, "The combination of our strategic choices and focus on operational excellence continue to drive competitive growth. Underlying sales growth is now at 4.4 percent for the year to date and we are confident that we will be well within our multi-year framework of 3-5 percent for the full year."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Frozen Food Development is recalling specific lots of Lidl branded 12-ounce packages of Frozen Chopped Spinach citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The product comes in 12-ounce poly bags, and items included in the recall are marked with lot # R17742 or R17963 on the back of the poly bag with a best by date of 09/10/23. Starbucks has dropped its vaccine or weekly test requirement against Covid-19 for U.S. employees in the wake of last week's U.S. Supreme Court ruling. The court, in a 6-3 vote, has blocked President Joe Biden's vaccine-or-test mandate for private companies with 100 or more employees. However, it allowed the vaccine mandate to stand for certain health care workers. Mylan Pharmaceuticals Inc., affiliated to healthcare company Viatris Inc., is recalling one batch of its non-interchangeable Semglee (insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens due to the potential for a missing label, the U.S. Food and Drug Administration said.
Follow RTT